Canadian Senate approves industry fees hike
This article was originally published in Clinica
The Canadian Senate adopted on 26 May proposals by Health Canada to allow it to increase user fees to medical device and pharmaceutical companies to cover its growing costs and workload delivering regulatory services. The proposals are expected to come into force in April 2011, officials have indicated.
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.